Product Information
QC TRIPLE ANTIBIOTIC OINTMENT is a generic product labeled by Chain Drug Marketing Association, priced at $0.1391 per GM under NDC 83324005005. Its NADAC has been published 95 times since Dec 11, 2024.
Strength
400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g
Manufacturer
Chain Drug Marketing AssociationNDC
83324005005
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
3/15/2024
Pharmacological Classes
Price Statistics
The NADAC for QC TRIPLE ANTIBIOTIC OINTMENT has been published 95 times since Dec 11, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1391 per GM |
|---|---|
| All-time high | $0.1410 (Dec 11, 2024) |
| All-time low | $0.1344 (Oct 22, 2025) |
| 52-week high | $0.1402 |
| 52-week low | $0.1344 |
| Median price | $0.1383 |
| Average price | $0.1384 |
| Largest weekly change | -2.5% (Dec 18, 2024) |
| Weeks tracked | 95 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate. market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate. market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC TRIPLE ANTIBIOTIC OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for QC TRIPLE ANTIBIOTIC OINTMENT, manufactured by Chain Drug Marketing Association, is $0.1391 per GM (NDC 83324005005), effective Sep 30, 2026.
How has the price of QC TRIPLE ANTIBIOTIC OINTMENT changed over time?
Over the history we have for it, the NADAC for QC TRIPLE ANTIBIOTIC OINTMENT has held within roughly two percent of its current level. It has been tracked across 95 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for QC TRIPLE ANTIBIOTIC OINTMENT?
Since Dec 11, 2024, the NADAC for QC TRIPLE ANTIBIOTIC OINTMENT has ranged from a low of $0.1344 (Oct 22, 2025) to a high of $0.1410 (Dec 11, 2024), with a median of $0.1383 per GM.
Are there cheaper alternatives to QC TRIPLE ANTIBIOTIC OINTMENT?
No other NADAC-published product currently shares the active ingredient and strength of QC TRIPLE ANTIBIOTIC OINTMENT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC TRIPLE ANTIBIOTIC OINTMENT?
QC TRIPLE ANTIBIOTIC OINTMENT (NDC 83324005005) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.